TG Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
01.11.23
/
50%
€9.50
Target price
01.11.24
€21.76
Performance (%)
120.99%
Price
28.08.24
€20.99
Summary
This prediction is currently active. With a performance of 120.99% the BUY prediction by JPMorgan_Chase___Co_ is a big success. This prediction currently runs until 01.11.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
TG Therapeutics Inc. | -6.607% | -6.607% |
iShares Core DAX® | 1.743% | 1.903% |
iShares Nasdaq 100 | -2.088% | -0.640% |
iShares Nikkei 225® | 1.306% | 4.161% |
iShares S&P 500 | -0.093% | 0.169% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread TG Therapeutics Inc. diskutieren
TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at JPMorgan Chase & Co. from $22.00 to $23.00. They now have an "overweight" rating on the stock.
Ratings data for TGTX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for TG Therapeutics Inc.
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.95
19.04.24
19.04.24
€23.48
19.04.25
19.04.25
62.08%
28.08.24
28.08.24
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.89
07.08.23
07.08.23
€19.99
07.08.24
07.08.24
106.21%
08.08.24
08.08.24